GNPX Genprex Forecast, Technical & Fundamental Analysis

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Get AI intraday signals

GNPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GNPX
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

GNPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GNPX
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

GNPX is expected to report earnings to fall 34.78% to -300 cents per share on March 29

Q4'23

Est.

$-3.00

Q3'23

Missed

by $4.50

Q2'23

Missed

by $5.07

Q1'23

Missed

by $6.24

Q4'22

Beat

by $0.02

The last earnings report on November 29 showed earnings per share of -459 cents, missing the estimate of -10 cents. With 15.23K shares outstanding, the current market capitalization sits at 3.90M.

A.I. Advisor

published General Information

General Information

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3300 Bee Cave Road

Phone

+1 877 774-4679

Employees

Web

https://www.genprex.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
EHAB	10.29	0.36	+3.63%
Enhabit
BXP	67.91	0.89	+1.33%
BXP Inc.
UFI	6.13	0.04	+0.66%
UNIFI
PSEC	5.51	0.01	+0.18%
Prospect Capital Corp
QH	0.47	N/A	-0.94%
Quhuo Limited

GNPX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

Ticker / NAME	Correlation To GNPX	1D Price Change %
GNPX	100%	+1.58%
REVB - GNPX	48% Loosely correlated	-1.82%
BCTX - GNPX	31% Poorly correlated	+0.64%
AXON - GNPX	30% Poorly correlated	-0.73%
TYRA - GNPX	30% Poorly correlated	-3.00%
GLPG - GNPX	30% Poorly correlated	+0.57%
More